Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths
One product is being pulled from the market, and the other is receiving updated instructions for use.
AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs
Researchers developed several new AI models that could guide the management of patients with non-valvular atrial fibrillation. There is still some work to do in terms of accuracy, but they already appear to outperform the traditional risk scores being used today.
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension
The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.
Philips pulls endovascular devices from market after safety issues prompt Class I recall
Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately.

Stroke care during the pandemic's first wave included younger patients, lower survival rates

More patients also required endovascular thrombectomy treatment than usual.

Risk of ischemic stroke much smaller with TAVR than SAVR when patient has a history of stroke

The new analysis included more than 92,000 TAVR patients and more than 68,000 SAVR patients.

Avoiding hospitals due to COVID-19 put heart attack, stroke patients on Medicare at risk

“Hospitalizations for acute myocardial infarction and stroke declined nationwide among adults during the early COVID-19 period, suggesting some patients did not receive timely care for these emergencies,” researchers said.

On-site stroke therapy tied to better clinical outcomes

A new analysis reveals that bringing stroke treatment to the patient yields better functional outcomes.

FDA grants breakthrough device designation to new chronic venous insufficiency device

A new clinical study is scheduled to begin in the near future.

American College of Chest Physicians updates recommendations for VTE management

The last update to these guidelines was published in 2016.

Doctors know best: Taking medications as recommended boosts survival for stoke patients

“The commonly used target of 80% medication adherence may be inappropriate for stratifying patients with stroke, as maximal survival benefits were observed above this arbitrary threshold,” researchers said.

Largest study of its kind highlights the link between COVID-19 and heart attack, stroke

A new analysis reveals that acute MI and ischemic stroke are a part of the clinical landscape of COVID-19 and highlights the need for vaccination against the virus.

Vascular & Endovascular

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

Philips pulls endovascular devices from market after safety issues prompt Class I recall